Literature DB >> 22288039

Contralateral ureteral metastasis 4 years after radical nephrectomy.

Hao-Jie Zhang1, Lu Sheng, Zhen-Wang Zhang, Zhong-Quan Sun, Wei-Qing Qian, Jian-da Song.   

Abstract

INTRODUCTION: Metastasis of renal cell carcinoma to the contralateral ureter is extremely rare. To date, only 50 cases of metastatic RCC to the ureter have been reported, among whom 6 cases occur at the contralateral site. We herein report a rare case of metastatic RCC in the contralateral ureter 4 years after radical nephrectomy. PRESENTATION OF CASE: A 74-year-old man presented with gross, painless hematuria for one month. Computed tomography scan confirmed that a 1.5 cm × 0.5 cm tumor occurred in the contralateral distal ureter. A 3.5 cm segment of ureter was resected and a uretero-vesical anastomosis with psoas hitch was accomplished. DISCUSSION: The reappearance of hematuria after radical nephrectomy is the most common manifestation of the metastasis to the bladder or ureter. The mechanism of metastasis is not clear. In pathology, vimentin and cytokeratins might help to differentiate between metastatic clear cell renal cell carcinoma and clear cell transitional cell carcinoma.
CONCLUSION: Metastasis of renal cell carcinoma to the contralateral ureter is rare. Early recognition is extremely important in protecting the remaining renal function and prolonging life-expectancy for post-nephrectomy patients. Complete metastectomy suitable anastomosis have been shown to improve survival.

Entities:  

Keywords:  Renal cell carcinoma; Ureteral metastasis

Year:  2011        PMID: 22288039      PMCID: PMC3267242          DOI: 10.1016/j.ijscr.2011.10.012

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  8 in total

1.  Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.

Authors:  S J Sim; J Y Ro; N G Ordonez; Y W Park; K H Kee; A G Ayala
Journal:  Mod Pathol       Date:  1999-04       Impact factor: 7.842

2.  Percutaneous management of grade II upper urinary tract transitional cell carcinoma: the long-term outcome.

Authors:  M E Jabbour; F Desgrandchamps; S Cazin; P Teillac; A Le Duc; A D Smith
Journal:  J Urol       Date:  2000-04       Impact factor: 7.450

3.  Transitional cell carcinoma exhibiting clear cell features. A differential diagnosis for clear cell adenocarcinoma of the urinary tract.

Authors:  S N Kotliar; C G Wood; A J Schaeffer; R Oyasu
Journal:  Arch Pathol Lab Med       Date:  1995-01       Impact factor: 5.534

4.  Urinary tract metastasis from renal carcinoma.

Authors:  J S Gelister; M Falzon; R Crawford; C R Chapple; W F Hendry
Journal:  Br J Urol       Date:  1992-03

5.  Renal cell carcinoma with solitary toe metastasis.

Authors:  Sisto Perdonà; Riccardo Autorino; Luigi Gallo; Marco DE Sio; Luigi Marra; Luigi Claudio; Corrado Caracò; Renato Franco; Flavio Fazzioli; Antonio Gallo
Journal:  Int J Urol       Date:  2005-04       Impact factor: 3.369

6.  Distant metastasis of renal adenocarcinoma in patients with a tumor thrombus in the renal vein and/or vena cava.

Authors:  H Saitoh
Journal:  J Urol       Date:  1982-04       Impact factor: 7.450

7.  Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: an institutional review.

Authors:  P C Kierney; J A van Heerden; J W Segura; A L Weaver
Journal:  Ann Surg Oncol       Date:  1994-07       Impact factor: 5.344

8.  Metastatic renal cell carcinoma to the bladder: case report and review of the literature.

Authors:  R E Remis; D B Halverstadt
Journal:  J Urol       Date:  1986-12       Impact factor: 7.450

  8 in total
  2 in total

1.  Clear cell renal cancer metastasis in the contralateral ureter: a case report.

Authors:  Julien Blanc; Beat Roth
Journal:  J Med Case Rep       Date:  2021-05-30

2.  Metastatic Renal Cell Carcinoma to the Contralateral Ureter: A Rare Phenomenon.

Authors:  Ashley Dixon; Maria Tretiakova; John Gore; Bryan B Voelzke
Journal:  Urol Case Rep       Date:  2015-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.